Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-blocker Treatment After AMI Without Reduced LVEF
NCT03646357Phase 4Active, not recruiting
- Sponsor
- Oslo University Hospital
- Start
- Oct 2018
- Primary completion
- Apr 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of metoprolol, bisoprolol, carvedilol in acute myocardial infarction (AMI), sponsored by Oslo University Hospital. Started Oct 2018; status: active, not recruiting.
02
Drugs
metoprololbisoprololcarvedilol
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT03646357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03646357.